Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 26, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Human ES cell derived cardiomyocytes for cell replacement therapy: a current update.

Michael Xavier Doss1, Agapios Sachinidis, Jürgen Hescheler

  • 1Center of Physiology and Pathophysiology, Institute of Neurophysiology, University of Cologne, Robert Koch Str. 39, 50931 Cologne, Germany.

The Chinese Journal of Physiology
|December 31, 2008
PubMed
Summary

Embryonic stem cells offer promise for cardiovascular repair, but ethical and practical challenges remain. Induced pluripotent stem cells present a viable alternative, avoiding embryo destruction and immune issues for regenerative medicine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structured, evidence-based debate in science: Introducing a new forum.

EXCLI journal·2026
Same author

The problem of weak AI-generated graphical abstracts.

EXCLI journal·2026
Same author

Scalable differentiation of human cardiac organoids from iPSCs generates cardiac tissues for cardiac cell therapy.

Theranostics·2026
Same author

Acute Depletion of Cited2 in Embryonic Stem Cells Disrupts Gene Networks Controlling Self-Renewal, Homeostasis, and Early Cell Fate Commitment.

Cells·2026
Same author

Loss of MLKL impairs abdominal aortic aneurysm development by attenuating smooth muscle cell necroptosis.

Cell death & disease·2026
Same author

Sex-specific cortical, hippocampal and thalamic whole genome transcriptome data from controls and a G72 schizophrenia mouse model.

BMC research notes·2024

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Disease Research
  • Stem Cell Biology

Background:

  • Cardiovascular diseases are the primary global cause of mortality.
  • Embryonic stem (ES) cells possess pluripotency and self-renewal capabilities, making them candidates for cell replacement therapy.
  • Current research shows encouraging results for human ES cells in myocardial repair, but the field is nascent.

Purpose of the Study:

  • To review the current status of human ES cell-based therapy for cardiovascular degenerative diseases.
  • To highlight the ethical and practical hurdles for clinical trials.
  • To explore the potential of induced pluripotent stem cells (iPSCs) as an alternative for cell replacement therapy.

Main Methods:

  • Literature review of existing studies on ES cells and iPSCs for cardiovascular repair.

More Related Videos

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
05:38

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Related Experiment Videos

Last Updated: Jun 26, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
05:38

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

  • Analysis of ethical considerations and practical applicability of stem cell therapies.
  • Comparison of ES cell-based therapy with iPSC-based therapy.

    • Main Results:

    • Human ES cells show potential for myocardial repair, but clinical application faces significant challenges.
    • Induced pluripotent stem cells (iPSCs) can be generated from adult fibroblasts, bypassing ethical concerns associated with embryonic stem cells.
    • iPSCs mitigate immunological rejection issues, offering a promising alternative for regenerative medicine.

    Conclusions:

    • Cell replacement therapy using stem cells holds significant potential for treating cardiovascular diseases.
    • Induced pluripotent stem cells represent a major advancement, overcoming key limitations of embryonic stem cell therapy.
    • Further research and resolution of challenges are necessary before widespread clinical adoption of either stem cell type.